Drugs / MRVAC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03713359 Comparator | Apr → Jul 2016 | — | Center for Research and Production of Vaccines and Biologicals, Vietnam | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MRVAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03713359 ↗ |
| Modality | Vaccine | “Measles-Rubella combined vaccine MRVAC produced by POLYVAC” NCT03713359 ↗ |
| Route | Subcutaneous | “Subcutaneous injection” NCT03713359 ↗ |